dihydroperilla alcohol | 100692-55-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: dihydroperilla alcohol
• 英文别名: phellandrol；(S)-p-menth-1-en-7-ol；(S)-1-Hydroxymethyl-4-isopropyl-cyclohexen-(1)；[(4S)-4-propan-2-ylcyclohexen-1-yl]methanol
• CAS: 100692-55-5
• 化学式: C₁₀H₁₈O
• 分子量: 154.252
• InChiKey: FFOYLHBMVUGHSX-SNVBAGLBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  dihydroperilla alcohol 在 chromium(VI) oxide 、 溶剂黄146 作用下， 生成 (S)-4-Isopropyl-cyclohex-1-enecarbaldehyde
  参考文献：
  名称：

  Kergomard; Philibert, Bulletin de la Societe Chimique de France, 1959, p. 1381,1384

  摘要：

  DOI：
• 作为产物：
  描述：

  (S)-(-)-紫苏醇 在 platinum(IV) oxide 氢气 作用下， 以96%的产率得到dihydroperilla alcohol
  参考文献：
  名称：

  烯丙基砜作为烯丙基锌在钯催化的锌-烯环化反应中的前体：对映纯（-）-红四烯的高效合成。

  摘要：

  易于制备的烯丙基苯基砜能够通过亲电α取代引入烯烃，优于乙酸烯丙酯作为Pd催化的Zn-烯环化的底物，提供具有顺式1,2-环的C5或C（4）N环。乙烯基和-CH（2）Zn取代基。提出了几种具有不同底物制备方法的实例。[反应：看文字]

  DOI：

  10.1021/ol051049i

文献信息

• [EN] COMPOSITIONS AND METHODS OF DECREASING MEDICATION ERRORS<br/>[FR] COMPOSITIONS ET MÉTHODES DESTINÉES À RÉDUIRE LES ERREURS DE MÉDICATION
  申请人：AZHC LLC

  公开号：WO2019014420A1

  公开（公告）日：2019-01-17

  The present disclosure provides for a method of decreasing medication errors by adding an odorant to a pharmaceutical composition comprising an active agent. The odorant has a distinct and characteristic odor. Thus, the pharmaceutical composition comprising the active agent can be properly identified by the characteristic odor.

  本公开提供了一种通过向包含活性成分的药物组合物中添加香料来减少药物错误的方法。该香料具有独特且特征性的气味。因此，可以通过这种特征性气味正确识别包含活性成分的药物组合物。
• [EN] PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES<br/>[FR] COMPOSITIONS PHARMACEUTIQUES COMPRENANT DES DÉRIVÉS DE POH
  申请人：NEONC TECH INC

  公开号：WO2021061752A1

  公开（公告）日：2021-04-01

  The present invention provides for a derivative of monoterpene or sesquiterpene, such as a perillyl alcohol derivative. For example, the perillyl alcohol derivative may be a perillyl alcohol carbamate. The perillyl alcohol derivative may be perillyl alcohol conjugated with a therapeutic agent such as a chemotherapeutic agent. The present invention also provides for a method of treating a disease such as a primary cutaneous lymphoma which may be a cutaneous T cell lymphoma (CTCL). The CTCL may be mycosis fungoides, primary cutaneous anaplastic large cell lymphoma (ALCL), or Sezary syndrome. A patient may be administered a therapeutically effective amount of a derivative of monoterpene (or sesquiterpene).

  本发明提供了一种单萜或倍半萜的衍生物，例如一种胡椒醇衍生物。例如，该胡椒醇衍生物可以是胡椒醇碳酰胺。胡椒醇衍生物可以是胡椒醇与治疗剂如化疗药物结合的产物。本发明还提供了一种治疗疾病的方法，例如原发皮肤淋巴瘤，可能是皮肤T细胞淋巴瘤（CTCL）。CTCL可能是真菌病样皮肤T细胞淋巴瘤、原发皮肤间变性大细胞淋巴瘤（ALCL）或塞扎里综合征。可以向患者施用一种单萜（或倍半萜）衍生物的治疗有效量。
• Inhibitory Effect of Perillosides A and C, and Related Monoterpene Glucosides on Aldose Reductase and Their Structure-Activity Relationships.
  作者：Tomoyuki FUJITA、Kumiko OHIRA、Kazutaka MIYATAKE、Yoshihisa NAKANO、Mitsuru NAKAYAMA

  DOI：10.1248/cpb.43.920

  日期：——

  Monoterpene glucosides, perillosides A and C, obtained from the leaves of Perilla frutescens, were found to be inhibitors of aldose reductase (EC 1.1.1.21) which is considered to be a key enzyme in diabetic complications such as cataract. The apparent type of inhibition of rat lens aldose reductase by perillosides A and C was competitive with respect to glyceraldehyde and their Ki values were 1.4×10-4 and 2.3×10-4M, respectively. The type of inhibition by their tetraacetates was non-competitive with respect to the same substrate, although their inhibitory effects were increased by about one order of magnitude compared with those of the perillosides and the Ki values were 2.5×10-5 and 7.1×10-5M, respectively. We also prepared related monoterpene glucosides and their tetraacetates and determined their inhibitory activities towards aldose reductase in order to elucidate the relationship between structure and inhibitory activity.

  从紫苏（Perilla frutescens）叶中获得的单萜葡萄糖苷，紫苏苷A和C，被发现是醛糖还原酶（EC 1.1.1.21）的抑制剂，该酶被认为是糖尿病并发症如白内障的关键酶。紫苏苷A和C对大鼠晶状体醛糖还原酶的抑制作用相对于甘油醛是竞争性的，其Ki值分别为1.4×10-4和2.3×10-4M。它们的四乙酸酯对同一底物的抑制类型是非竞争性的，尽管其抑制效果比紫苏苷提高了大约一个数量级，Ki值分别为2.5×10-5和7.1×10-5M。我们还制备了相关的单萜葡萄糖苷及其四乙酸酯，并测定了它们对醛糖还原酶的抑制活性，以便阐明结构与抑制活性之间的关系。
• Synthesis of N-heterocycles, beta-amino acids, and allyl amines via aza-payne mediated reaction of ylides and hydroxy aziridines
  申请人：Borhan Babak

  公开号：US20090012120A1

  公开（公告）日：2009-01-08

  An ylide-based aza-Payne rearrangement of 2,3-aziridin- 1 -ols leads to an efficient process for the preparation of pyrrolidines. The aza-Payne rearrangement under the basic reaction conditions favors the formation of epoxy amines. Subsequent nucleophilic attack of the epoxide by the ylide yields a bis-anion, which upon a 5-exo-tet ring closure yields the desired pyrrolidine, thus completing the relay of the 3-membered the 5-membered nitrogen containing ring system. This process takes place with complete transfer of stereochemical fidelity, and can be applied to sterically hindered aziridinols.

  基于叶立德的2,3-氮杂环丙醇的aza-Payne重排反应导致了一种高效的吡咯烷制备过程。在碱性反应条件下进行的aza-Payne重排有利于环氧胺的形成。叶立德对环氧化物的亲核攻击产生双阴离子，随后通过5-内攻环闭合产生所需的吡咯烷，从而完成了含3-成员和5-成员氮环的环的传递。这个过程完全保持立体化学的保真度，并可应用于立体位阻的氮杂环丙醇。
• 10.1016/j.tet.2024.134070
  作者：Xu, Zhi、Airan, Yougant、Tomanik, Martin、Yang, Andrew T.、Bhak, Natalie、Herzon, Seth B.

  DOI：10.1016/j.tet.2024.134070

  日期：——

  we attempted to carry out an intramolecular cyclopropanation of an allylic diazoester containing an electronically-unbiased alkene embedded in a 6-oxa-bicyclo[3.2.1]-oct-3-ene skeleton. We obtained exclusively a product arising from 1,2-addition of oxygen and carbon (oxyalkylation) to the alkene. While oxyalkylation products have been reported when electron-rich alkenes (e.g. enol ethers) are employed

  通过烯丙基重氮酯的环化合成环丙烷是众所周知的。在之前针对倍半萜类卫矛醇的研究中，我们尝试对包含嵌入 6-氧杂-双环[3.2.1]-辛-3-烯骨架中的电子无偏烯烃的烯丙基重氮酯进行分子内环丙烷化。我们独家获得了由氧和碳与烯烃进行 1,2-加成（烷氧基化）而产生的产物。虽然已经报道了当使用富电子的烯烃（例如烯醇醚）时产生的烷氧基化产物，但源自电子不偏向的烯烃的烷氧基化产物是罕见的。在这里，我们确定烷氧基化对于一系列 6-氧杂-双环[3.2.1]-辛-3-烯底物是普遍的，并表明这些产物在更简单的 α-重氮-β-酮酯的环化中竞争形成。我们的数据表明，增加过渡态的电荷分离可以促进烷氧基化途径。